Status:
ACTIVE_NOT_RECRUITING
Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Genes
Sporadic Chordoma
Eligibility:
All Genders
6-99 years
Brief Summary
Background: Chordoma is a rare, slow growing, often fatal bone cancer derived from remnants of the embryonic notochord. It occurs mostly in the axial skeleton (skull base, vertebrae, sacrum and coccy...
Detailed Description
Synopsis Background: Chordoma is a rare, slow growing, often fatal bone cancer derived from remnants of the embryonic notochord. It occurs mostly in the axial skeleton (skull base, vertebrae, sacrum ...
Eligibility Criteria
Inclusion
- ELIGIBILITY CRITERIA:
- To be eligible subjects must be at least 6 years old at the time of enrollment, be the only person in their family ever diagnosed with chordoma, and reside in the U.S or Canada.
- Chordoma in the patients can have been diagnosed at any age and any primary site.
Exclusion
Key Trial Info
Start Date :
January 2 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
188 Patients enrolled
Trial Details
Trial ID
NCT01200680
Start Date
January 2 2011
Last Update
December 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Westat, Inc.
Rockville, Maryland, United States, 20850